首页|Amsterdam University Medical Center Reports Findings in Pancreatoduodenectomy (E arly experience with robotic pancreatoduodenectomy versus open pancreatoduodenec tomy: nationwide propensity-score-matched analysis)
Amsterdam University Medical Center Reports Findings in Pancreatoduodenectomy (E arly experience with robotic pancreatoduodenectomy versus open pancreatoduodenec tomy: nationwide propensity-score-matched analysis)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Surgery-Pancreatoduo denectomy is the subject of a report. According to news reporting from Amsterdam, Netherlands, by NewsRx journalists, research stated, "Although robotic pancrea toduodenectomy has shown promising outcomes in experienced high-volume centres, it is unclear whether implementation on a nationwide scale is safe and beneficia l. The aim of this study was to compare the outcomes of the early experience wit h robotic pancreatoduodenectomy versus open pancreatoduodenectomy in the Netherl ands." The news correspondents obtained a quote from the research from Amsterdam Univer sity Medical Center, "This was a nationwide retrospective cohort study of all co nsecutive patients who underwent robotic pancreatoduodenectomy or open pancreato duodenectomy who were registered in the mandatory Dutch Pancreatic Cancer Audit (18 centres, 2014-2021), starting from the first robotic pancreatoduodenectomy p rocedure per centre. The main endpoints were major complications (Clavien-Dindo grade greater than or equal to III) and in-hospital/30-day mortality. Propensity -score matching (1 : 1) was used to minimize selection bias. Overall, 701 patien ts who underwent robotic pancreatoduodenectomy and 4447 patients who underwent o pen pancreatoduodenectomy were included. Among the eight centres that performed robotic pancreatoduodenectomy, the median robotic pancreatoduodenectomy experien ce was 86 (range 48-149), with a 7.3% conversion rate. After match ing (698 robotic pancreatoduodenectomy patients versus 698 open pancreatoduodene ctomy control patients), no significant differences were found in major complica tions (40.3% versus 36.2% respectively; P = 0.186), in-hospital/30-day mortality (4.0% versus 3.1% respe ctively; P = 0.326), and postoperative pancreatic fistula grade B/C (24.9% versus 23.5% respectively; P = 0.578). Robotic pancreatoduodenecto my was associated with a longer operating time (359 min versus 301 min; P<0.001), less intraoperative blood loss (200 ml versus 500 ml; P<0.001), fewer wound infections (7.4% versus 12.2%; P = 0.008), and a shorter hospital stay (11 days versus 12 days; P<0.001). Centres performing greater than or equal to 20 robotic pancreatoduodene ctomies annually had a lower mortality rate (2.9% versus 7.3% ; P = 0.009) and a lower conversion rate (6.3% versus 11.2% ; P = 0.032). This study indicates that robotic pancreatoduodenectomy was safely implemented nationwide, without significant differences in major morbidity and mortality compared with matched open pancreatoduodenectomy patients."
AmsterdamNetherlandsEuropeEmerging TechnologiesGastroenterologyHealth and MedicineHospitalsMachine Learnin gPancreatoduodenectomyRoboticsRobotsSurgery
NETL
NSTL
